Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Corrigendum to: Dual IRE 1 RN ase functions dictate glioblastoma development (EMBO Molecular Medicine, (2018), 10, 3, 10.15252/emmm.201707929)

Lhomond S. et al, (2023), EMBO Molecular Medicine, 15

Spatially resolved clonal copy number alterations in benign and malignant tissue.

Erickson A. et al, (2022), Nature, 608, 360 - 367

Dual IRE1 RNase functions dictate glioblastoma development

Lhomond S. et al, (2022), EMBO Molecular Medicine, 14

Inhibition of CDK9 activity compromises global splicing in prostate cancer cells.

Hu Q. et al, (2021), RNA Biol, 18, 722 - 729

Peptidomimetic‐based identification of FDA‐approved compounds inhibiting IRE1 activity

Doultsinos D. et al, (2021), The FEBS Journal, 288, 945 - 960

Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges.

Doultsinos D. and Mills IG., (2021), Cancers (Basel), 13

Pharmacological Targeting of IRE1 in Cancer

Raymundo DP. et al, (2020), Trends in Cancer, 6, 1018 - 1030

The role of the androgen receptor as a driver and mitigator of cellular stress.

Doultsinos D. and Mills I., (2020), J Mol Endocrinol, 65, R19 - R33

Endoplasmic reticulum stress signalling – from basic mechanisms to clinical applications

Almanza A. et al, (2019), FEBS Journal, 286, 241 - 278

Dual IRE1 RNase functions dictate glioblastoma development

Lhomond S. et al, (2018), EMBO Molecular Medicine, 10

Control of the Unfolded Protein Response in Health and Disease

Doultsinos D. et al, (2017), SLAS Discovery, 22, 787 - 800

Include forthcoming?